Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions.

已完结 10 由 wzy123 发布于 2025/7/6 16:40:39

DOI:10.1080/14737140.2024.2414071
作者：Aram Bidikian,?Jan P Bewersdorf,?Rory M Shallis,?Ted M Getz,?Jessica M Stempel,?Tariq Kewan,?Maximilian Stahl,?Amer M Zeidan
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Introduction: Myelodysplastic syndromes/neoplasms (MDS) are a heterogeneous group of hematologic malignancies that are stratified into high-risk (HR-MDS) and low-risk (LR-MDS) categories. Un

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureAI-generated literature reviews threaten scientific progress